Literatur
-
1
Burge PS, Calverley P M, Jones P W, Spencer S, Anderson J A.
Prednisolone response in patients with chronic obstructive pulmonary disease: results from the ISOLDE study.
Thorax.
2003;
58
654-658
-
2
Burge P S, Calverley P M, Jones P W, Spencer S, Anderson J A, Maslen T K.
Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial.
BMJ.
2000;
320
1297-1303
-
3
Calverley P, Pauwels R, Vestbo J. et al .
Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial.
Lancet.
2003;
361
449-456
-
4
Calverley P M, Burge P S, Spencer S, Anderson J A, Jones P W.
Bronchodilator reversibility testing in chronic obstructive pulmonary disease.
Thorax.
2003;
58
659-664
-
5
Gillissen A, Barczok M, Buhl R. et al .
Inhalierbare Kortikosteroide in der Langzeittherapie der COPD: Stellungnahme eines Expertengremiums.
Pneumologie.
2000;
54
256-262
-
6
Murray C JL, Lopez A D.
Alternative projections of mortality and disability by cause 1990 - 2020: Global Burden of Disease Study.
Lancet.
1997;
349
1498-1504
-
7
Pauwels R A, Löfdahl C G, Laitinen L A. et al .
Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease.
N Engl J Med.
1999;
340
1948-1953
-
8
Scanlon P D, Connett J E, Waller L A. et al .
Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study.
Am J Respir Crit Care Med.
2000;
161
381-390
-
9
Szafranski W, Cukier A, Ramirez A. et al .
Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease.
Eur Respir J.
2003;
21
74-81
-
10
Vestbo J, Soerensen T, Lange P. et al .
Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial.
Lancet.
1999;
353
1819-1823
-
11
Worth H, Buhl R, Cegla U. et al .
Leitlinie der Deutschen Atemwegsliga und der Deutschen Gesellschaft für Pneumologie zur Diagnostik und Therapie von Patienten mit chronisch obstruktiver Lungenerkrankung (COPD).
Pneumologie.
2002;
56
704-738
Dr. Peter Kardos
Gemeinschaftspraxis, & Allergologisches Zentrum, Klinik Maingau vom roten Kreuz
Scheffelstraße 2-16
60318 Frankfurt am Main
Telefon: +49/69/4033282
Fax: +49/69/594781
eMail: kardos@lungenpraxis-maingau.de
